Effect of transdermal oestradiol on the haemostatic balance of menopausal women. 1993

J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
Midlands Menopause Study Group: Birmingham Maternity Hospital, UK.

OBJECTIVE To determine the effect of transdermal oestrogen replacement therapy on the haemostatic balance of menopausal women. METHODS Open, parallel group, prospective study. METHODS Three hospital-based menopause clinics. METHODS Fifty-two postmenopausal women receiving transdermal hormone replacement therapy (Estrapak 50) for 6 months. Comparison group of 48 untreated postmenopausal women studied in parallel. METHODS Changes in platelet number, plasma concentrations of coagulation factors and their natural inhibitors, fibrinolytic activity, and rheological parameters. RESULTS Estrapak 50 had no significant thrombophilic effect on any of the outcome measures. CONCLUSIONS The haemostatic balance and thus the risk of thrombosis would not appear to be upset by this dose of transdermal oestrogen.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses

Related Publications

J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
September 1999, British journal of obstetrics and gynaecology,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
April 2007, Thrombosis and haemostasis,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
April 1976, Thrombosis and haemostasis,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
September 1947, Deutsche medizinische Wochenschrift (1946),
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
December 1988, Maturitas,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
June 1996, European journal of obstetrics, gynecology, and reproductive biology,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
January 2015, Annals of agricultural and environmental medicine : AAEM,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
October 2018, The British journal of general practice : the journal of the Royal College of General Practitioners,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
October 1990, British journal of obstetrics and gynaecology,
J Fox, and A J George, and J R Newton, and A D Parsons, and G K Stuart, and J Stuart, and D W Sturdee
July 1978, Clinical endocrinology,
Copied contents to your clipboard!